FDA
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update
-
-
-
-
-
-
-
Brainstorm Cell Therapeutics (BCLI) Secures Manufacturing Partnership with Minaris
-
-
-
-
-
-
-
BrainStorm to Present Biomarker Insights Supporting NurOwn's Mechanism of Action and Clinical Impact at the 2025 ALS Drug Development Summit
-
-
-
-
-
-
-
BrainStorm to Announce Fourth Quarter and Fiscal Year 2024 Financial Results and Provide a Corporate Update
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting
-
322,093 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

